期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Glomus tumor of uncertain malignant potential of the brachial plexus: A case report 被引量:2
1
作者 Pichaya Thanindratarn Thanapon Chobpenthai +1 位作者 Termphong Phorkhar Scott D Nelson 《World Journal of Clinical Cases》 SCIE 2019年第18期2815-2822,共8页
BACKGROUND Glomus tumor is an uncommon benign tumor usually presenting with a small mass occurring in the dermis or soft tissue of an extremity, especially subungual region. However, intraneural glomus tumor is sporad... BACKGROUND Glomus tumor is an uncommon benign tumor usually presenting with a small mass occurring in the dermis or soft tissue of an extremity, especially subungual region. However, intraneural glomus tumor is sporadic. While most of the glomus tumors are benign, atypical glomus tumors with unusual features can be occasionally found, leading to distinctive malignant potential required different therapeutic approaches. Glomus tumor of uncertain malignant potential is one type of atypical glomus tumor with limited criteria for malignancy and without metastasis. CASE SUMMARY Herein, we report a case of a 48-year-old Thai male with a large painful mass in his axilla for one year without apparent neurological deficit. Magnetic resonance imaging showed a large heterogeneous mass encasing entire posterior cord of left brachial plexus and axillary artery. The tumor tissue from core needle biopsy histologically demonstrated the sheets and cords of relatively uniform tumor cells with foamy cytoplasm and round to oval hyperchromatic nuclei without atypia. The mitotic count was 0 per 50 high power field. A final diagnosis of glomus tumor of uncertain malignant potential was rendered. Complete surgical resection was performed, followed by adjuvant radiation due to positive margin. Neither local recurrence nor distant metastasis was observed at 2-year follow up. Unfortunately, postoperative incomplete brachial plexopathy without signs of reinnervation by electromyography was persisted. Later nerve grafting reconstruction was performed, followed by ongoing neurological rehabilitation. CONCLUSION Glomus tumor of uncertain malignant potential is exceedingly rare, especially around brachial plexus. Although the prognosis is good, careful histological diagnosis and treatment are needed to achieve an optimal outcome with lower morbidity. 展开更多
关键词 GLOMUS TUMOR GLOMUS TUMOR of UNCERTAIN MALIGNANT potential BRACHIAL PLEXUS Case report
下载PDF
Design,characterisation,and clinical evaluation of a novel porous Ti-6Al-4V hemipelvic prosthesis based on Voronoi diagram
2
作者 Zhuangzhuang Li Yi Luo +6 位作者 Minxun Lu Yitian Wang Linsen Zhong Yong Zhou Zhenfeng Duan Li Min Chongqi Tu 《Biomaterials Translational》 2024年第3期314-324,共11页
Three-dimensional printed Ti-6Al-4V hemipelvic prosthesis has become a current popular method for pelvic defect reconstruction.This paper presents a novel biomimetic hemipelvic prosthesis design that utilises patient-... Three-dimensional printed Ti-6Al-4V hemipelvic prosthesis has become a current popular method for pelvic defect reconstruction.This paper presents a novel biomimetic hemipelvic prosthesis design that utilises patient-specific anatomical data in conjunction with the Voronoi diagram algorithm.Unlike traditional design methods that rely on fixed,homogeneous unit cell,the Voronoi diagram enables to create imitation of trabecular structure(ITS).The proposed approach was conducted for six patients.The entire contour of the customised prosthesis matched well with the residual bone.The porosity and pore size of the ITS were evaluated.The distribution of the pore size ranged from 500 to 1400μm.Porosity calculations indicated the average porosity was 63.13±0.30%.Cubic ITS samples were fabricated for micrograph and mechanical analysis.Scanning electron microscopy images of the ITS samples exhibited rough surface morphology without obvious defects.The Young’s modulus and compressive strength were 1.68±0.05 GPa and 174±8 MPa,respectively.Post-operative X-rays confirmed proper matching of the customised prostheses with the bone defect.Tomosynthesis-Shimadzu metal artifact reduction technology images indicated close contact between the implant and host bone,alongside favourable bone density and absence of resorption or osteolysis around the implant.At the last follow-up,the average Musculoskeletal Tumour Society score was 23.2(range,21-26).By leveraging additive manufacturing and Voronoi diagram algorithm,customised implants tailored to individual patient anatomy can be fabricated,offering wide distribution of the pore size,reasonable mechanical properties,favourable osseointegration,and satisfactory function. 展开更多
关键词 3D printing biomimetic prosthesis bone tumour pelvic defect reconstruction porous structure
原文传递
siltuximab单克隆抗体对卵巢上皮性癌中白细胞介素6/Stat3信号传导通路的影响 被引量:2
3
作者 郭玉琪 路平 +1 位作者 DUAN Zhen-feng 张展 《中华妇产科杂志》 CAS CSCD 北大核心 2010年第11期854-859,共6页
目的 探讨白细胞介素6(IL-6)单克隆抗体--siltuximab对卵巢上皮性癌(卵巢癌)中IL-6/信号传导及转录活化因子3(Stat3)信号传导通路的影响.方法 (1)选取美国哈佛大学麻省总医院近20年来确诊为卵巢癌的26例患者的癌组织标本,每例... 目的 探讨白细胞介素6(IL-6)单克隆抗体--siltuximab对卵巢上皮性癌(卵巢癌)中IL-6/信号传导及转录活化因子3(Stat3)信号传导通路的影响.方法 (1)选取美国哈佛大学麻省总医院近20年来确诊为卵巢癌的26例患者的癌组织标本,每例患者的标本均包含原发性、转移性和复发性癌组织,免疫组化法检测26例卵巢癌患者癌组织中IL-6蛋白的表达;(2)蛋白印迹法检测IL-6、siltuximab联合IL-6处理后卵巢癌细胞株SKOV3细胞中磷酸化Stat3(pStat3)蛋白的表达,以及siltuximab处理后卵巢癌紫杉醇耐药细胞株SKOV3/TR和CAOV3/TR细胞中Stat3介导的抗凋亡蛋白--bcl-XL、MCL-1、survivin蛋白的表达;(3)实时细胞技术检测siltuximab联合IL-6处理后SKOV3-pEGFP-Stat3细胞中pEGFP-Stat3融合蛋白的核转移情况;(4)四甲基偶氮唑蓝比色法检测siltuximab处理后SKOV3/TR和CAOV3/TR细胞对紫杉醇的敏感性,以50%抑制浓度(IC50)表示.结果 (1)卵巢癌患者转移性和复发性癌组织中IL-6蛋白的染色强度明显高于原发性癌组织;且转移性和复发性癌组织中IL-6蛋白的阳性表达率[分别为69%(18/26)和77%(20/26)]明显高于原发性癌组织[23%(6/26),P<0.05].(2)IL-6处理的SKOV3细胞中pStat3蛋白的表达强度明显高于未经IL-6处理者;siltuximab(浓度分别为0.01、0.1、1和10μg/ml)联合IL-6处理后,SKOV3细胞中pStat3蛋白的表达强度随siltuximab浓度的增加明显减弱;经不同浓度(0.001、0.01、0.1、1、10μg/ml)的siltuximab处理后,SKOV3/TR和CAOV3/TR细胞中bcl-XL、MCL-1、survivin蛋白的表达强度均明显低于未经siltuximab处理者.(3)IL-6处理后,pEGFP-Stat3融合蛋白迅速转移到SKOV3-pEGFP-Stat3细胞的细胞核中;siltuximab(浓度分别为0.001、0.01、0.1、1、10μg/ml)联合IL-6处理后,pEGFP-Stat3融合蛋白的核转移随siltuximab浓度的增加逐渐减少.(4)不同浓度的siltuximab(分别为1、10 μg/ml)处理后,SKOV3/TR细胞对紫杉醇的IC50(分别为0.49和0.19μg/ml)明显低于未经siltuximab处理者(0.71μg/ml;P<0.05);CAOV3/TR细胞对紫杉醇的IC50(分别为0.0010和0.0008μg/ml)明显低于未经siltuximab处理者(0.0021 μg/ml;P<0.01).结论 siltuximab能有效阻断卵巢癌中IL-6/Stat3信号传导通路,可能对卵巢癌的治疗有重要作用. 展开更多
关键词 抗体 单克隆 卵巢肿瘤 白细胞介素6 STAT3转录因子 信号传导
原文传递
IL-6/STAT3信号传导通路及其在肿瘤靶向治疗中的作用 被引量:5
4
作者 郭玉琪 Zhenfeng Duan 张展 《国际肿瘤学杂志》 CAS 2011年第6期427-429,共3页
白细胞介素-6(IL-6)与肿瘤患者的分期、预后、转归以及对化疗药物的敏感性有关,且在患者的肿瘤组织及血清中常呈过表达。IL-6主要通过介导信号转换和转录激活因子3(STAT3)信号传导通路(IL-6/STAT3信号传导通路)来调节肿瘤细胞... 白细胞介素-6(IL-6)与肿瘤患者的分期、预后、转归以及对化疗药物的敏感性有关,且在患者的肿瘤组织及血清中常呈过表达。IL-6主要通过介导信号转换和转录激活因子3(STAT3)信号传导通路(IL-6/STAT3信号传导通路)来调节肿瘤细胞的增殖和分化。因此,IL-6/STAT3信号传导通路的阻断,对肿瘤具有潜在治疗意义。 展开更多
关键词 肿瘤 白细胞介素6 STAT3转录因子 信号传导
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部